Sequential treatment with targeted and immune checkpoint inhibitor therapies in patients with BRAF positive metastatic melanoma: Real-world data.

被引：0
|
作者：
Cybulska-Stopa, Bozena
Czarnecka, Anna Malgorzata
Ostaszewski, Krzysztof
Piejko, Karolina
Zietek, Marcin
Dziura, Robert
Rutkowska, Ewa
Galus, Lukasz
Ziolkowska, Barbara
Kempa-Kaminska, Natasza
Seredynska, Joanna
Kamycka, Agnieszka
Bal, Wieslaw
Surus-Hyla, Anna
Switaj, Tomasz
Rogala, Pawel
Kaminska-Winciorek, Grazyna
Suwinski, Rafal
Mackiewicz, Jacek
Rutkowski, Piotr
机构：
[1] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Clin Oncol, Cracow Branch, Krakow, Poland
[2] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland
[3] Wroclaw Med Univ, Dept Oncol, Wroclaw, Poland
[4] Wroclaw Comprehens Canc Ctr, Dept Surg Oncol, Wroclaw, Poland
[5] Holy Cross Canc Ctr, Dept Clin Oncol, Kielce, Poland
[6] Univ Med Sci, Dept Med & Expt Oncol, Heliodor Swiecicki Clin Hosp, Poznan, Poland
[7] Maria Sklodowska Curie Natl Res Inst Oncol, Clin Radiotherapy & Chemotherapy 2, Gliwice Branch, Gliwice, Poland
[8] Wroclaw Comprehens Canc Ctr, Dept Clin Oncol, Wroclaw, Poland
[9] Podkarpacki Centrum Onkol Rzeszowie, Rzeszow, Poland
[10] Gliwice Oncol Inst, Gliwice, Poland
[11] Minist Interior & Adm Hosp, Clin Dept Oncol & Immuno Oncol, Warmian Masurian Canc Ctr, Olsztyn, Poland
[12] Maria Sklodowska Curie Natl Res Inst Oncol, Gliwice Branch, Dept Bone Marrow Transplantat & Onco Hematol, Skin Canc & Melanoma Team, Gliwice, Poland
[13] Greater Poland Canc Ctr, Dept Diagnost & Canc Immunol, Poznan, Poland
[14] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21539
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world analyses of therapy discontinuation of checkpoint inhibitors in metastatic melanoma patients
    Machado, Marina Amaral de Avila
    de Moura, Cristiano Soares
    Chan, Kelvin
    Curtis, Jeffrey R.
    Hudson, Marie
    Abrahamowicz, Michal
    Jamal, Rahima
    Pilote, Louise
    Bernatsky, Sasha
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [22] Real-world treatment patterns and outcomes in patients with metastatic melanoma
    Dokanovic, Dejan
    Lazic, Bojana
    Gojkovic, Zdenka
    Cvijetic, Zeljka
    Sokolovic, Emir
    Ceric, Timur
    Jungic, Sasa
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2023, 151 (3-4) : 209 - 215
  • [23] Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting
    Pedersen, Sidsel
    Larsen, Kirstine Ostenfeld
    Christensen, Alex Horby
    Svane, Inge Marie
    Zerahn, Bo
    Ellebaek, Eva
    ACTA ONCOLOGICA, 2022, 61 (01) : 45 - 51
  • [24] Real-world data on PD-1 inhibitor therapy in metastatic melanoma
    Arheden, Anna
    Skalenius, Joanna
    Bjursten, Sara
    Stierner, Ulrika
    Ny, Lars
    Levin, Max
    Jespersen, Henrik
    ACTA ONCOLOGICA, 2019, 58 (07) : 962 - 966
  • [25] Real-world data for immune checkpoint inhibitor therapy as first line treatment of recurrent or metastatic squamous cell cancer of the head and neck
    Wagner, S. M.
    Magnes, T.
    Minichsdorfer, C.
    Gamerith, G.
    Pall, G.
    Greil, R.
    Melchardt, T.
    Fuereder, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 132 - 133
  • [26] Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma
    Kim, Roger Y.
    Mitra, Nandita
    Bagley, Stephen J.
    Marmarelis, Melina E.
    Haas, Andrew R.
    Rendle, Katharine A.
    Vachani, Anil
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (06):
  • [27] Risk factors for myocarditis associated with immune checkpoint inhibitors using real-world clinical data.
    Jain, Prantesh
    Bugarin, Jahir Gutierrez
    Guha, Avirup
    Jain, Chhavi
    Shen, Tingke
    Stanevich, Ilya
    Margevicius, Seunghee P.
    Fu, Pingfu
    Liu, Fang
    Nikore, Vipan
    Mangla, Ankit
    De Lima, Marcos J. G.
    Velcheti, Vamsidhar
    Barnholtz-Sloan, Jill
    Dowlati, Afshin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Real-world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer
    Xu, Ting
    Li, Jian
    Wang, Zhenghang
    Zhang, Xiaotian
    Zhou, Jun
    Lu, Zhihao
    Shen, Lin
    Wang, Xicheng
    CANCER MEDICINE, 2023, 12 (09): : 10473 - 10484
  • [29] Targeted agents or immuno-oncology therapies as first-line therapy for BRAF-mutated metastatic melanoma: a real-world study
    Luke, Jason J.
    Ghate, Sameer R.
    Kish, Jonathan
    Lee, Choo Hyung
    McAllister, Lindsay
    Mehta, Sonam
    Ndife, Briana
    Feinberg, Bruce A.
    FUTURE ONCOLOGY, 2019, 15 (25) : 2933 - 2942
  • [30] Treatment of BRAF-mutated metastatic melanoma patients with targeted therapy combinations or immunotherapy in real world setting.
    Ocvirk, Janja
    Ignjatovic, Marija
    Rebersek, Martina
    Boc, Marko
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345